Augmentation cystoplasty and simultaneous ureteral reimplantation reduce high-grade vesicoureteral reflux in children with neurogenic bladder  by Wang, Jen-Bin et al.
Available online at www.sciencedirect.comJournal of the Chinese Medical Association 74 (2011) 294e297
www.jcma-online.comOriginal Article
Augmentation cystoplasty and simultaneous ureteral reimplantation reduce
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Received June 17, 2010; accepted January 31, 2011AbstractBackground: To compare the incidence of residual high-grade vesicoureteral reflux (HVUR) (Grade III) in neurogenic bladder patients
receiving augmentation cystoplasty alone or with simultaneous ureteral reimplantation. Furthermore, we also tried to find the risk factors of
residual VUR and febrile urinary tract infection.
Methods: Between 1999 and 2009, urinary bladder augmentation was performed in 21 children with neurogenic bladder. Seventeen of these
patients had VUR on preoperative voiding cystourethrography, of whom 11 patients (14 ureters) received augmentation alone (Group A) and
6 patients (8 ureters) received simultaneously ureteral reimplantation (Group B). Univariate logistic regression analysis and Fisher exact test
were used for statistical analysis.
Results: Six patients (8 ureters) had residual HVURs in Group A, but none in Group B. The incidences of residual HVUR were 57.14% and 0%,
respectively. Seven patients had febrile UTIs after operation, 6 of them had residual HVURs. In risk factor analysis, postoperative follow-up
duration less than 12 months and lack of anti-reflux operation were significant risk factors for residual HVUR; the residual HVUR was the
significant risk factor for febrile urinary tract infection.
Conclusion: Simultaneous ureteral reimplantation reduces postop HVUR significantly. We recommend augmentation and simultaneous ureteral
reimplantation in children with HVUR and neurogenic bladder if technically feasible.
Copyright  2011 Elsevier Taiwan LLC and the Chinese Medical Association. All rights reserved.
Keywords: Augmentation cystoplasty; Neurogenic bladder; Ureteral reimplantation; Vesicoureteral reflux1. Introduction
Vesicoureteral reflux (VUR) is a common problem associ-
ated with neurogenic bladder. High-grade VUR (HVUR)
(Grade IIIeV) may increase the risks of febrile urinary tract
infection (UTI) and renal damage.1 Augmentation cystoplasty
(AC) increases bladder volume, decreases intravesical pressure,
and improves bladder compliance in patients with neurogenic* Corresponding author. Dr. Tai-Wai Chin, Division of Pediatric Surgery,
Department of Surgery, Taipei Veterans General Hospital, 201, Section 2,
Shih-Pai Road, Taipei 112, Taiwan, ROC.
E-mail address: twchin@vghtpe.gov.tw (T.-W. Chin).
1726-4901/$ - see front matter Copyright  2011 Elsevier Taiwan LLC and the C
doi:10.1016/j.jcma.2011.05.004bladder. In the literature, many authors believe that AC alone is
enough to resolve VUR in neurogenic bladder and that it is not
necessary to perform simultaneous ureteral reimplantation.2,3
Previously at our institute (from 1999 to 2003), most patients
who received AC also had simultaneous reimplantation if they
were complicated with VUR. However, simultaneous reim-
plantation was not performed after August 2003 because of
a change in our policy. Since then, we have noticed a high rate
of failure to eliminate VUR in those patients who had AC
only, similar to other reports.4 To decide whether simultaneous
ureteral reimplantation should be performed during AC, we
assessed the outcomes of residual HVUR in our patients.
Furthermore, we also investigated the risk factors of febrile
UTI and residual VUR.hinese Medical Association. All rights reserved.
Table 1
Characteristics of the Group A receiving bladder augmentation only
Case Age (yr)/sex Underlying disease Op age (yr) Material used Preop VUR
(grade)
Postop VUR
(grade)
Postop febrile
UTI
Right Left Right Left
1 22/F MMC 16 Ileum 5 0 0 0 No
2 25/M LMC 21 Ileum 4 5 0 5 Yes
3 20/F MMC 12 Ileum 5 4 0 5 Yes
4 5/F LMC 3 Ileum 0 5 0 0 No
5 16/M MMC 15 Ileum 0 5 0 0 No
6 10/M MMC 9 Sigmoid 1 5 0 0 No
7 8/M LMC 7 Ileum 0 3 0 0 No
8 10/F Cauda equina syndrome 10 Ileum 5 5 5 5 Yes
9 15/F SBO 14 Ileum 5 0 5 0 Yes
10 3/F MMC 3 Ileum 5 3 3 4 Yes
11 6/F Transverse myelitis 6 Ileum 3 2 3 3 Yes
F ¼ female; LMC ¼ lipomeningocele; M ¼ male; MMC ¼ myelomeningocele; Op ¼ operation; Postop ¼ postoperative; Preop ¼ preoperative; SBO ¼ spinal
bifida occulta; UTI ¼ urinary tract infection; VUR ¼ vesicoureteral reflux.
Table 2
Characteristics of the Group B receiving bladder augmentation and ureteral
reimplantation
Case Age
(yr)/sex
Underlying
disease
Op age
(yr)
Material
used
Preop
VUR
(grade)
Postop
VUR
(grade)
Postop
febrile UTI
Right Left Right Left
1 12/F Sarcral
agenesis
2 Ileum 4 0 0 0 No
2 12/F SBO 3 Ileum 4 4 0 0 No
3 11/F MMC 3 Ileum 4 4 0 0 No
4 15/F SBO 8 Ileum 0 5 0 0 No
5 15/F SBO 8 Sigmoid 0 3 0 1 Yes
6 10/M SBO 4 Ileum 0 4 0 0 No
F ¼ female; M ¼ male; MMC ¼ myelomeningocele; Op ¼ operation;
Postop ¼ postoperative; Preop ¼ preoperative; SBO ¼ spinal bifida occulta;
UTI ¼ urinary tract infection; VUR ¼ vesicoureteral reflux.
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We retrospectively reviewed 28 patients with neurogenic
bladder who underwent AC during 1999e2009 in our hospital.
The characteristics of the patients are listed in Table 1. The
indications for AC were either deterioration of renal function
or urine incontinence. Of these patients, one died from an
unrelated cause and six were lost to follow-up (6 patients had
augmentation only and one had concomitant left reimplanta-
tion), leaving a total of 21 patients (14 girls and 7 boys) for
analysis. Preoperative evaluation included renal function,
voiding cystourethrography (VCUG), urodynamic study
(including maximal detrusor pressure, leaking point pressure)
and renal ultrasonography. Urodynamic findings were typical,
with small bladder volume and high intravesical pressure in all
patients. The VUR was graded according to the International
Reflux Study Group classification.5
Of the 21 patients, 17 patients showed initial HVUR on
preoperative VCUG, composed of 22 ureters with Grade
IIIeV VUR. Patients received AC plus reimplantation from
1999e2003, and AC only after August 2003 because of
a departmental policy change. The patients were thus divided
into two groups according to whether or not simultaneous
ureteral reimplantation was performed while the patients were
receiving AC.
The ureteral reimplantations were conducted using the
Cohen cross-trigonal technique. A fine ureteral stent was
placed or not according to the friability of the mucosa and
condition of the ureteral orifice. If placed, it was removed on
Day 3 after AC. These patients were followed with VCUG,
renal function, and renal sonography 3e6 months after the
operation in the initial period, and yearly thereafter when
stable. No patients had urodynamic study after the operation.
In the search for the risk factors for residual VURs and
febrile UTIs, several factors were assessed and defined. The risk
factors included age at operation (>10 years), duration of
follow-up (12 months), poor catheterization compliance
[clean intermittent catheterization (CIC) 3 times/day], small
bladder volume {maximum catheterization volume< expected
bladder volume, [age (yrs)þ2]  30 mL}, presence of vesiclestones, and presence of bladder trabeculation. Univariate
logistic regression analysis and Fisher’s exact test were used for
statistical analysis. A p value<0.05 was considered statistically
significant.
3. Results
The patients’ characteristics are shown in Tables 1 and 2.
Overall, 17 patients of the 21 patients had initial HVUR on
preoperative VCUG. Of these patients, 11 patients (14 ureters)
received AC alone and were assigned to Group A. Six patients
(8 ureters) received simultaneous ureteral reimplantation
during AC and were assigned to Group B. Residual HVUR
was assessed by VCUG periodically until resolution. At the
end of the study, 6 patients (8 ureters) in Group A and none in
Group B had residual HVUR. The incidence of residual
HVUR was 57.14% (8 of 14 ureters) in Group A versus 0%
(0 of 8 ureters) in Group B. The characteristics of patient
and grades of initial and residual HVUR are listed in Tables 1
and 2, respectively. Comparing the grades of VUR before and
after operation, 7 ureters showed improvement, 5 remained
unchanged, 2 worsened in Group A, and all 8 ureters in Group
B showed improvement.
Table 3
Univariate logistic regression analysis of risk factors for residual HVUR
Risk factor Patients with
HVUR (n ¼ l6)
Patient without
HVUR (n ¼ 11)
Odds ratio 95%
CI (lowereupper)
pa
Age at op >10 yr 4 2 9.000 (0.914e88.575) 0.109
Postop duration less than 12 mo 3 0 e 0.029
Small bladder volume 0 3 e 0.515
Poor CIC compliance 5 3 13.333 (1.069e166.374) 0.050
Bladder trabeculation 4 8 0.075 (0.087e6.468) 1.000
Without anti-reflux surgery 0 (n ¼ 8 ureters) 8 (n ¼ 14 ureters) e 0.018
a Fisher exact test.
CIC ¼ clean intermittent catheterization; CI ¼ confidence interval; HVUR ¼ high-grade vesicoureteral reflux; Op ¼ operation; Postop ¼ postoperative.
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catheterization increased from an average of 257 mL to
418 mL following AC. The change of catheterized bladder
volume was from 255  166 mL to 412  186 mL in Group A
and from 275  103 mL to 433  112 mL in Group B
( p ¼ 0.755). The volume percentage increases in Groups A
and B were 62% and 58%, respectively. Seven patients
experienced episodes of febrile UTIs during the postoperative
follow-up period, and 6 of them had residual VURs.
The risks factors for residual VURs and febrile UTIs were
analyzed and are listed in Tables 3 and 4. We found that the
postoperative duration ( p ¼ 0.029) and whether or not anti-
reflux operations were performed ( p ¼ 0.018) were signifi-
cant risk factors for residual HVURs. Poor catheterization
compliance was a borderline risk factor ( p ¼ 0.05). For risk
factors related to febrile UTI, residual HVUR was a significant
risk factor ( p < 0.01).
4. Discussion
In the management of patients with neurogenic bladder, the
aim is to increase bladder compliance, lower intravesical pres-
sure, achieve satisfactory continence, and avoid renal damage.
AC is an effective way to improve urodynamics.6 However,
a significant amount of residual VUR presents after the
augmentation, especially if patients are high Grade (IIIeV)
preoperatively.3 In the literature, the incidence of residual
VUR after AC alone ranges from 0% to 47.3%.2,3,7e9 When
concomitant anti-reflux operations are applied, the incidence
reduces to about 4%.4 In our study, simultaneous ureteral
reimplantation also achieved a low rate of residual HVURwhenTable 4
Univariate logistic regression analysis of risk factors for febrile UTI
Risk factor Patients with
UTI (n ¼ 7)
Patient w
UTI (n
Age at op >10 yr 5 4
Postop duration less than 12 mo 3 2
Bladder stones 1 2
Poor CIC compliance 5 3
Small bladder volume 3 8
Residual VUR 6 0
Bladder trabeculation 5 11
a Fisher exact test.
CIC ¼ clean intermittent catheterization; CI ¼ confidence interval; Op ¼ operation
reflux.compared with AC alone (0% vs. 57.14%). The high residual
rate in AC alone may be attributed to the shorter follow-up
duration of the patients with persistent reflux in Group A.
Many authors suggest performing bladder augmentation
alone in the management of neurogenic bladder, commonly
stating that VURs are secondary to noncompliant, high-pres-
sure bladders. By improving the dynamics of neurogenic
bladder with AC, the refluxes may resolve by themselves.
However, a recent study reported VURs persisting despite
a low-pressure bladder after bladder augmentation.9 It is
assumed a primary ureterotrigonal insufficiency (short sub-
mucosal tunnel) exists and causes the persistent VUR after
augmentation. Furthermore, some authors discourage ureteral
reimplantation in a hypertrophied, trabeculated bladder with
fragile mucosa because of technical difficulties, which
increase the risk of postoperative ureteral obstruction.10 One
patient in our series had bilateral ureteral obstruction after
Cohen operation, and she needed reoperation for placement of
the ureteral stent.
VUR is an important factor for upper UTIs and renal
damage.1 In our series, 7 patients experienced febrile UTIs
during follow-up, and 6 of them had residual VURs. This
finding implies a relationship between reflux and febrile UTIs.
We further assessed the risk factors contributing to febrile
UTIs and residual VURs. The analysis revealed that a short
postoperative duration, defined as less than 12 months, and
a lack of anti-reflux surgery were significant risk factors for
residual VURs. We hypothesize that this may be because the
bladder compliance was low immediately after the operation.
It takes time for the augmented bowel to expand and become
more compliant. Residual VUR is a significant risk factor forithout
¼ 14)
Odds ratio 95% CI (lowereupper) pa
6.875 (0.931e50.782) 0.074
4.875 (0.590e40.258) 0.274
1.083 (0.081e14.412) 1.000
10.000 (1.260e79.333) 0.052
1.524 (0.250e9.295) 1.000
e <0.001
0.909 (0.123e6.715) 1.000
; Postop ¼ postoperative; UTI ¼ urinary tract infection; VUR ¼ vesicoureteral
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best to avoid residual HVURs.
Poor compliance with CIC can be a confounding factor of
postoperative UTI and residual VUR. All the 5 patients with
poor compliance with CIC had residual high-grade VUR. The
p values of risk factors for residual HVUR and UTI were 0.05
and 0.052 respectively. The results show the importance of
compliance in catheterization. Without good compliance for
CIC, residual HVUR and UTI may occur.
In our series, a high rate of residual reflux was noted as
compared to most of the previous investigations. We do not
know if this is related to a shorter postoperative follow-up
duration or a higher percentage of primary reflux in these
patients. But the data show that simultaneous anti-reflux
surgery may reduce the incidence of residual reflux. This
study is limited by small sample size. A larger randomized
study may further clarify the issue.References
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